Cerebral infarction following intravenous immunoglobulin therapy for Guillain-Barre syndrome

VELİOĞLU S., Özmenoǧlu M., BOZ C.

Journal of Stroke and Cerebrovascular Diseases, vol.10, no.6, pp.290-292, 2001 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 10 Issue: 6
  • Publication Date: 2001
  • Doi Number: 10.1053/jscd.2001.123772
  • Journal Name: Journal of Stroke and Cerebrovascular Diseases
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.290-292
  • Keywords: Cerebral infarction, Guillain-Barre syndrome, Intravenous immunoglobulin
  • Karadeniz Technical University Affiliated: Yes


Intravenous immunoglobulin (IvIg) therapy is used increasingly for different immune-mediated diseases, such as the Guillain-Barre syndryyome. We report the case of a 55-year-old man who developed a cerebral infarction 2 days after completion of treatment with intravenous immunoglobulin for Guillain-Barre syndrome. Copyright © 2001 by National Stroke Association.